Absci (ABSI) Stock Analysis

What Absci does

Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.

Key metrics

ETFs linked to ABSI

Broad-market and Healthcare sector ETFs an investor holding Absci is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ABSI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Absci?

Absci trades under the ticker ABSI on NASDAQ.

Which exchange is ABSI listed on?

ABSI is listed on NASDAQ.

What sector does Absci operate in?

Absci is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ABSI in a portfolio?

PortView shows ABSI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.